Cher S. Chuah
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Patient-led thematic analysis on the impact of living with inflammatory bowel disease: a contemporary appraisal of 415 patient-reported outcomes to improve care and research.
Journal: Crohn's & colitis 360
Published: May 01, 2025
A chemiluminescence assay targeting granzyme A activity for monitoring inflammatory bowel disease.
Journal: Nature biomedical engineering
Published: November 09, 2023
Formylated Peptide Receptor-1-Mediated Gut Inflammation as a Therapeutic Target in Inflammatory Bowel Disease.
Journal: Crohn's & colitis 360
Published: August 17, 2023
Letter: non-selective beta-blockers in cirrhosis-effect beyond portal hypertension. Authors' reply.
Journal: Alimentary pharmacology & therapeutics
Published: June 10, 2022
Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding-long-term follow-up of a randomised control trial.
Journal: Alimentary pharmacology & therapeutics
Published: January 10, 2022
Carvedilol is associated with improved survival in patients with cirrhosis: a long-term follow-up study.
Journal: Alimentary pharmacology & therapeutics
Published: September 05, 2020
Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort.
Journal: Journal of gastroenterology and hepatology
Published: June 05, 2020
Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn's Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: November 11, 2019
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort.
Journal: Journal of Crohn's & colitis
Published: February 16, 2019
Association of trough vedolizumab levels with clinical, biological and endoscopic outcomes during maintenance therapy in inflammatory bowel disease.
Journal: Frontline gastroenterology
Published: February 07, 2019
Last Updated: 09/26/2026